Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors

Islets

Volumn 3, Issue 6, 2011, Pages 344-351

  Tomita, Tatsuo ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Islet amyloid polypeptide; Pancreatic endocrine tumors; Pancreatic islets

Indexed keywords

AMYLIN; CHROMOGRANIN A; GASTRIN; GLUCAGON; INSULIN; SOMATOSTATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INSULINOMA; LIVER METASTASIS; MALE; NON BETA CELL PANCREATIC ENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; PANCREATIC POLYPEPTIDOMA; SOMATOSTATINOMA;

FEMALE; GLUCAGON; GLUCAGONOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INSULINOMA; ISLET AMYLOID POLYPEPTIDE; MALE; PANCREATIC NEOPLASMS; SOMATOSTATIN;

EID: 80455143209     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.3.6.17866     Document Type: Article

References (25)

1. Westermark P, Westermark C, Wilander E, Stetten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986; 140:827-31; PMID:3535798; DOI:10.1016/0006-291X(86)90708-4.
2. Cooper GJ, Willis AC, Clark A, Turnfer RC, Sim RB, Reid KB. Purification and characterization of peptide from amyloid-rich pancreas of type 2 diabetic pancreas. Proc Natl Acad Sci USA 1987; 84:8628-32; PMID:3317417; DOI:10.1073/pnas.84.23.8628.
3. Kahn SE, Andrikopoulos S, Verchere CB. Islet amyloid: a long-recognized but under-appreciated pathological feature of type 2 diabetes. Diabetes 1999; 48:241-53; PMID:10334297; DOI:10.2337/diabetes.48.2.241.
4. Höper JWM, Ahren B, Lips CJM. Islet amyloid and type 2 diabetes mellitus. N Engl J Med 2000; 343:411-9; PMID:10933741; DOI:10.1056/ NEJM200008103430607.
5. Portela-Gomes GFM, Johansson H, Olding L, Grimelius L. Co-localization of neuroendocrine hormones in the fetal pancreas. Eur J Endocrinol 1999; 141:526-33; PMID:10576771; DOI:10.1530/eje.0.1410526.
6. Iki K, Pour PM. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2-diabetic cases. J Histochem Cytochem 2007; 55:111-8; PMID:16982850; DOI:10.1369/jhc.6A7024.2006.
7. Tomita T. Amylin in pancreatic islets and pancreatic endocrine neoplasms. Pathol Int 2003; 53:591-5; PMID:14507315; DOI:10.1046/j.1440-827.2003.01532.x.
8. Hayek A, Bebattie GM. Experimental transplantation of human fetal and adult pancreatic islets. J Clin Endocrinol Metab 1997; 82:2471-5; PMID:9253320; DOI:10.1210/jc.82.8.2471.
9. Rindi G, Terenghi G, Westermark G, Westermark P, Moscoso G, Polak J. Islet amyloid polypeptide in proliferating pancreatic β-cells during development. Am J Pathol 1991; 138:1321-34; PMID:1647136.
10. Tomita T. Amylin in human adult pancreatic islets. Pathol Int 2003; 53:591-5; PMID:14507315; DOI:10.1046/j.1440-827.2003.01532.x.
11. Fineman M, Weyer C, Maggs E, Strobel S, Kolterman OG. The human amylin analog, Pramlintide reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res 2002; 34:504-8; PMID:12384827; DOI:10.1055/s-2002-34790.
12. Eissele R, Neuhaus C, Trautmann ME, Funk A, Arnold R, Hofler H. Immunoreacting and expression of amylin in gastropancreatic endocrine tumors. Am J Pathol 1993; 143:283-91; PMID:8317551.
13. Bordi C, Pilato FP, D'Adda T. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours. Virchows Arch A Pathol Anat Histopathol 1988; 413:387-98; PMID:2845642; DOI:10.1007/BF00716987.
14. Tomita T, Friesen SR, Kimmel JR, Doull V, Pollock HG. Pancreatic polypeptide-secreting islet cell tumors. A study of three cases. Am J Pathol 1983; 113:134-42; PMID:6314815.
15. Tomita T, Iwata K. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors. Mod Pathol 1997; 10:47-54; PMID:9021726.
16. Tomita T. Metallothionine in pancreatic endocrine tumors. Mod Pathol 2000; 13:389-95; PMID:10786804; DOI:10.1038/modpathol.3880064.
17. Tomita T. Immunocytochemical staining of cleaved caspase-3 for pancreatic islets from type 2 diabetic subjects. Pathology 2010; 42:432-7; PMID:20632819; DOI:10.3109/00313025.2010.493863.
18. Kolterman OG, Gottlieb A, Moyses C, Colburn W. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 1995; 18:1179-82; PMID:7587855; DOI:10.2337/diacare.18.8.1179.
19. Hayden MR, Tyagi SC. "A" for amylin and amyloid in type 2 diabetes mellitus. JOP 2001; 2:124-39; PMID:11875249.
20. Buse JB, Weyer C, Maggs DG. Amylin replacement with Pramlintide in type 1 and type 2 diabetes: A physiological approach to overcome barriers with insulin therapy. Clin Diabetes 2002; 20:137-44; DOI:10.2337/diaclin.20.3.137.
21. Lorenzo A, Razzabony B, Weir GC, Yankner BA. Pancreatic islet toxicity of amylin associated with type 2 diabetes mellitus. Nature 1994; 368:756-60; PMID:8152488; DOI:10.1038/368756a0.
22. Jaikaran ET, Clark A. Islet amyloid and type 2 diabetes: from molecular, misfolding to islet pathophysiology. Biochim Biophys Acta 2001; 1537:179-203; PMID:11731221.
23. Marzban L, Park K, Verchere CB. Islet amyloid polypeptide and type 2 diabetes. Exp Gerontol 2003; 38:347-51; PMID:12670620; DOI:10.1016/S0531- 5565(03)00004-4.
24. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: A critical entity in the pathogenesis of type2 diabetes. J Clin Endocrinol Metab 2004; 89:3629-43; PMID:15292279; DOI:10.1210/jc.2004-0405.
25. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987; 57:230-6; PMID:2441141.